NCT00266578View on ClinicalTrials.gov

A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

November 30, 2006

Study Completion Date

October 31, 2012

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

Fluticasone Propionate

Flovent vs. placebo daily for 3 months

Trial Locations (1)

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Marc Rothenberg

OTHER

NCT00266578 - A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders | Biotech Hunter | Biotech Hunter